Roche will publish its Sales Results for the 1st Quarter of 2022 prior to the opening of the Swiss Stock Exchange on Monday, 25 April 2022. 

07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before) 

Release will be e-mailed and posted on the Roche IR website > click here 
Presentation slides will be posted on the Roche IR website > click here 

14:00 – 15:30 CEST / 13:00 – 14:30 BST 
08:00 – 09:30 AM EDT / 05:00 - 06:30 AM PDT 

The webinar will start with presentations by senior management, followed by a Q&A session. 

Presenters:

 

• Severin Schwan, CEO Roche Group
• Bill Anderson, CEO Roche Pharmaceuticals
• Thomas Schinecker, CEO Roche Diagnostics
• Alan Hippe, Chief Financial and IT Officer 
  
   

We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.* 
Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. 

A replay of the webcast will be available via > ir.roche.com 
*privacy notice 

Best regards, 

Bruno Eschli                                         
Head of Investor Relations